Controlled Therapeutics Ltd
Controlled Therapeutics (Scotland) Ltd (CT) is a drug delivery technology company. The company commercializes its polymer drug delivery technology which is capable of providing controlled release of a range of drug molecules over periods up to 24 hours. Its key objective is to develop, manufacture and license pharmaceutical products based on patented drug delivery technologies. The company also conducts research and development. The 3,500 sq. meter building houses the manufacturing facility that has been approved by government agencies to enable its dinoprostone controlled release insert to be manufactured and exported to many markets around the world. CT is a wholly owned subsidiary of Cytokine PharmaSciences Inc. (CPSI). CT together with CPSI are actively interested in research and developing a number of new products. CT is focused on the products that are currently in Phases I through to III. CT is headquartered in East Kilbride, the UK.